Page 10 - Anna Ljung News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anna ljung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anna Ljung Today - Breaking & Trending Today

OncoZenge expands the board with Hilde Furberg

OncoZenge expands the board with Hilde Furberg
Search jobs
OncoZenge expands the board with Hilde Furberg
OncoZenge AB (publ) (“OncoZenge”), Moberg Pharma AB (publ)’s subsidiary, has at an Extraordinary Shareholders Meeting today resolved on expanding the board with Hilde Furberg ahead of the listing on Nasdaq First North Growth Market, which is planned to take place during the first quarter of 2021.
Hilde Furberg (born 1958) represents Linc AB and is an independent consultant and a professional board member. She has broad senior leadership experience, coming from her over 35 years in sales, marketing, strategy and general management roles in pharmaceuticals and biotechnology. Her experience is in different areas of specialty care, and from small to large global companies. Hilde has worked in companies like Baxter and Genzyme, and she was most recently the European Head of Rare Diseases for Sanofi Genzyme. Hilde has also been a boa ....

Hilde Furberg , Anna Ljung , Moberg Pharma , Sanofi Genzyme , Pirkko Tamsen , Oslo University , Extraordinary Shareholders Meeting , Nasdaq First North Growth Market , European Head , Rare Diseases , Small Cap , Nasdaq Stockholm , மொபெர்க் பார்மா , ஒசிலோ பல்கலைக்கழகம் , அசாதாரண பங்குதாரர்கள் சந்தித்தல் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை , ஐரோப்பிய தலை , ரேர் நோய்கள் , சிறிய தொப்பி , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் ,

OncoZenge raises MSEK 10 ahead of spin-off and separate listing

OncoZenge raises MSEK 10 ahead of spin-off and separate listing
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Anna Ljung , Moberg Pharma , Pirkko Tamsen , Directed Issue , Nasdaq First North Growth Market , Small Cap , Nasdaq Stockholm , மொபெர்க் பார்மா , இயக்கியது பிரச்சினை , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை , சிறிய தொப்பி , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் ,

OncoZenge raises MSEK 10 ahead of spin-off and separate listing

/PRNewswire/ OncoZenge AB (publ) ("OncoZenge"), Moberg Pharma AB (publ) s subsidiary, has today resolved on a directed share issue in accordance with the. ....

Anna Ljung , Moberg Pharma , Pirkko Tamsen , Directed Issue , Nasdaq First North Growth Market , மொபெர்க் பார்மா , இயக்கியது பிரச்சினை , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை ,